Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2013.02.023
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2013
Authors
Publisher
Elsevier BV